Bing-Hui Yang

Summary

Country: China

Publications

  1. ncbi request reprint [Community hospital should set up general internal medical unit]
    Bing Hui Yang
    Zhonghua Nei Ke Za Zhi 42:675. 2003
  2. ncbi request reprint [Supplement but not replacement]
    Bing Hui Yang
    Zhonghua Nei Ke Za Zhi 44:725. 2005
  3. ncbi request reprint [Changes of clinical aspect of primary liver cancer in China during the past 30 years--control study for 3,250 cases with primary liver cancer]
    Bing Hui Yang
    Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai 200032, China
    Zhonghua Yi Xue Za Zhi 83:1053-7. 2003
  4. ncbi request reprint Randomized controlled trial of screening for hepatocellular carcinoma
    Bo Heng Zhang
    Liver Cancer Institute of Fudan University, Zhongshan Hospital, 180 Feng Lin Road, Shanghai 200032, China
    J Cancer Res Clin Oncol 130:417-22. 2004
  5. ncbi request reprint Changed clinical aspects of primary liver cancer in China during the past 30 years
    Bing Hui Yang
    Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai 200032, China net
    Hepatobiliary Pancreat Dis Int 3:194-8. 2004

Collaborators

  • Bo Heng Zhang
  • Zhao You Tang

Detail Information

Publications5

  1. ncbi request reprint [Community hospital should set up general internal medical unit]
    Bing Hui Yang
    Zhonghua Nei Ke Za Zhi 42:675. 2003
  2. ncbi request reprint [Supplement but not replacement]
    Bing Hui Yang
    Zhonghua Nei Ke Za Zhi 44:725. 2005
  3. ncbi request reprint [Changes of clinical aspect of primary liver cancer in China during the past 30 years--control study for 3,250 cases with primary liver cancer]
    Bing Hui Yang
    Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai 200032, China
    Zhonghua Yi Xue Za Zhi 83:1053-7. 2003
    ..To study the changes of the clinical aspects of primary liver cancer (PLC) during the past 30 years...
  4. ncbi request reprint Randomized controlled trial of screening for hepatocellular carcinoma
    Bo Heng Zhang
    Liver Cancer Institute of Fudan University, Zhongshan Hospital, 180 Feng Lin Road, Shanghai 200032, China
    J Cancer Res Clin Oncol 130:417-22. 2004
    ..The aim of this study was to assess the effect of screening on HCC mortality in people at increased risk...
  5. ncbi request reprint Changed clinical aspects of primary liver cancer in China during the past 30 years
    Bing Hui Yang
    Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai 200032, China net
    Hepatobiliary Pancreat Dis Int 3:194-8. 2004
    ..In the past 30 years, the diagnosis and treatment of PLC have been greatly improved with better prognosis...